LINC01641: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01641

NCBI ID: G107985463

LINC01641

Other Name(s): long intergenic non-protein coding RNA 1641 | Long intergenic non-protein coding RNA 1641

LINC01641: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01641 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a unique feature, which is its ability to interact with small molecules and drugs, making it an attractive candidate for drug discovery. LINC01641 has also been shown to play a role in various biological processes, including cell signaling, gene regulation, and tissue development.

Drug Discovery and LINC01641 as a Potential Drug Target

The search for new drug targets is a continuous process that has led to the development of many effective drugs. Many of these drugs work by interacting with specific protein targets. However, there is a growing interest in finding drugs that target non-protein-coding RNAs (ncRNAs), such as LINC01641, as these molecules have been shown to play important roles in various biological processes and are potential drug targets.

LINC01641 has been shown to interact with small molecules and drugs that can modulate its expression levels. This interactivity makes LINC01641 an attractive target for drug discovery. Several studies have shown that LINC01641 can be modulated by small molecules, including inhibitors of RNA polymerase II (RNA-pro), which is a key enzyme in the regulation of gene expression.

In addition, LINC01641 has also been shown to interact with drugs that target specific pathways, such as the PI3K/Akt signaling pathway. This interaction suggests that LINC01641 may be a useful drug target for diseases associated with this pathway, such as cancer and neurodegenerative diseases.

Biomarker Development

LINC01641 has also been shown to be involved in various biological processes, including cell signaling and gene regulation. This suggests that it may be a useful biomarker for certain diseases. For example, LINC01641 has been shown to be involved in the regulation of cell proliferation and has been linked to the development of cancer.

In addition, LINC01641 has also been shown to play a role in tissue development and maintenance. This suggests that it may be a useful biomarker for diseases associated with tissue development, such as regenerative diseases.

Conclusion

In conclusion, LINC01641 is a long intergenic non-protein-coding RNA that has unique features, including its ability to interact with small molecules and drugs. These properties make LINC01641 an attractive candidate for drug discovery and biomarker development. Further studies are needed to fully understand the role of LINC01641 in various biological processes and to determine its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1641

The "LINC01641 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01641 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets